From indomethacin to a selective COX-2 i
โ
W.C. Black; C. Bayly; M. Belley; C.-C. Chan; S. Charleson; D. Denis; J.Y. Gauthi
๐
Article
๐
1996
๐
Elsevier Science
๐
English
โ 307 KB
A series of potent and highly selective cyclooxygenase-2 inhibitors have been prepared by replacing the benzoyl group of indomethacin with a 4-bromobenzyl group, and by extending the acetic acid side chain. These compounds show anti-inflammatory activity in rats with no evidence of GI toxicity, even